aav

Latest content and products

Industry NewsLife Sciences

eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture

27 May 2025

Industry NewsLife Sciences

Andelyn Biosciences AAV Curator Platform used to manufacture clinical grade viral vector for FDA-authorized first-in-world universal donor CRISPR/AAV transduced CAR-NK cells

8 May 2025

Product NewsSpectroscopy

HORIBA announces new Veloci BioPharma Analyzer for biopharma and pharma applications

14 Mar 2025

Webinars

TechTalk: Fast, accurate, accessible quantification across diverse biologics

Speakers: Dr. Paolo Romele, Abselion

23 Jan 2026

Watch on-demand

Advancing light scattering assays for AAV products

Speakers: Dr Margaret Butko, Adverum, Dr. Prithwijit Sarkar, Waters|Wyatt Technology, Olivia Long, SelectScience

19 Mar 2025

Watch on-demand

Resources

White Papers

Rethinking nuclease strategy to improve yield, product quality, and manufacturing economics in viral vector production

12 Jan 2026

Infographic

3 alternatives for DNA removal in AAV manufacturing

21 Oct 2025

White Papers

CQA analysis for AAV drug production by multiple workflows on a single CE platform

3 Jul 2025

Application Note

Analysis of partial capsids using Vericheck ddPCR Empty-Full Capsid Kit

4 Nov 2024

News

Industry News

eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture

27 May 2025

Industry News

Andelyn Biosciences AAV Curator Platform used to manufacture clinical grade viral vector for FDA-authorized first-in-world universal donor CRISPR/AAV transduced CAR-NK cells

8 May 2025

Ruizhi Wang, CEO, Abselion with the Amperia at-line protein analyser

Industry News

Abselion raises £6.6M led by M Ventures to bring Amperia to market

9 Dec 2024

Industry News

Comparison of analytical approaches for AAV characterization

13 Jul 2023

aav